You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

What Have We Learned About Innovative Approaches to ASCVD, and What Should We Do?

  • Authors: Kausik K. Ray, MD, MPhil, FRCP; Christie M. Ballantyne, MD; Alberico L. Catapano, MDHc, PhD
  • CPD Released: 10/15/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 10/15/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for primary care physicians.

The goal of this activity is to provide an overview of important data, guidelines, and news on novel lipid therapies approved in 2021.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Latest scientific and clinical trial data on small interfering RNA therapies to reduce low-density lipoprotein cholesterol
    • Latest scientific and clinical trial data on reducing lipoprotein(a)
  • Have greater competence related to
    • Applying the latest insights in atherosclerotic cardiovascular disease (ACVD) management to clinical practice


Disclosures

WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.


Faculty

  • Kausik K. Ray, MD, MPhil, FRCP

    Professor of Public Health
    Honorary Consultant Cardiologist
    Imperial Centre for Cardiovascular Disease Prevention
    Department of Primary Care & Public Health
    Imperial College London
    London, United Kingdom

    Disclosures

    Disclosure: Kausik K. Ray, MD, MPhil, FRCP, has the following relevant financial relationships:
    Advisor or consultant for: Amgen; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Kowa; Novartis; Novo Nordisk; Pfizer
    Speaker or a member of a speakers bureau for: Amgen; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Kowa; Novartis; Novo Nordisk; Pfizer; Sanofi
    Grants for clinical research from: Amgen; Daiichi Sankyo; Regeneron
    Stocks, stock options, or bonds from: Pemi31 Therapeutics

  • Christie M. Ballantyne, MD

    Professor of Medicine
    Chief, Sections of Cardiology and Cardiovascular Research
    Director, Center for Cardiometabolic Disease Prevention
    Baylor College of Medicine
    Houston, Texas, United States

    Disclosures

    Disclosure: Christie M. Ballantyne, MD, has the following relevant financial relationships:
    Advisor or consultant for: Abbott Diagnostics; Akcea; Althera; Amarin; Amgen; Arrowhead; AstraZeneca; Corvidia; Denka Seiken; Esperion; Gilead; Janssen; Matinas BioPharma Inc.; New Amsterdam; Novartis; Novo Nordisk; Pfizer; Regeneron; Roche Diagnostics; Sanofi-Genzyme
    Grants for clinical research from: Abbott Diagnostic; ADA; AHA; Akcea; Amgen; Esperion; NIH; Novartis; Regeneron; Roche Diagnostic

  • Alberico L. Catapano, MDHc, PhD

    Professor of Pharmacology
    Director, Laboratory of Lipoprotein Metabolism
    Department of Pharmacological Sciences
    University of Milan
    Director, Center for Study of Atherosclerosis
    Bassini Hospital
    Milan, Italy

    Disclosures

    Disclosure: Alberico L. Catapano, MDHc, PhD, has the following relevant financial relationships:
    Advisor or consultant for: Aegerion; Akcea; Amgen; Daiichi Sankyo; Esperion; Genzyme; Ionis Pharmaceuticals; Kowa; Menarini; Merck; Mylan; Recordati; Sandoz; Sanofi
    Speaker or a member of a speakers bureau for: Aegerion; Akcea; Amgen; Daiichi Sankyo; Esperion; Genzyme; Ionis Pharmaceuticals; Kowa; Menarini; Merck; Mylan; Recordati; Sandoz; Sanofi
    Grants for clinical research from: Amgen; Eli Lilly; Menarini; Mylan; Sanofi; Sanofi Regeneron

Editor

  • Ozerk Akgun, MD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Ozerk Akgun, MD, has disclosed no relevant financial relationships.

Content Reviewer

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

What Have We Learned About Innovative Approaches to ASCVD, and What Should We Do?

Authors: Kausik K. Ray, MD, MPhil, FRCP; Christie M. Ballantyne, MD; Alberico L. Catapano, MDHc, PhDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CPD Released: 10/15/2021

Valid for credit through: 10/15/2022

processing....

 

 

  • Print